Light at the end of the pipeline

The recent spate of newspaper stories about Calgene Inc.'s genetically engineered tomato has deflected attention from the rest of the agbio group, which, after years of promises, is finally poised to bring products to market this year and next.

While the group hasn't done all that well in the past couple of years, things could look up for the stocks once products do come to market.